Image created by Dr. Michael J. Miller
The FDA cleared the Vitek Compact Pro by bioMérieux for microorganism identification (ID) and antibiotic susceptibility testing (AST) to help clinical laboratories diagnose infectious diseases and combat antimicrobial resistance, and industrial laboratories to identify contaminants for ensuring consumer safety.
Every year, 11 million people worldwide die of sepsis (Lancet 2020;395[10219]:200-211), and 1.3 million of these deaths are attributable to antibiotic-resistant bacteria (Lancet 2022;399[10325]:629-655). Antimicrobial resistance (AMR) continues unabated, making detection of resistant pathogens more complex. Clinicians need to receive accurate ID and faster AST results to enable timely and optimized patient intervention.
The Vitek Compact Pro combines the latest diagnostic technology with the globally acknowledged advantages of its predecessor: the Vitek 2 Compact. With an ergonomically advanced design and simplified workflow, it further enhances the user experience and improves overall efficiency, as the laboratory technician has to spend less time for sample loading and processing. It offers an efficient workflow, fastest routine ID/AST results and microbiology expertise for accurate and confident diagnostics insight. Ideally suited for small and medium-sized laboratories, the Vitek Compact Pro will also enable laboratories transitioning from manual workflows to benefit from automation efficiencies.
“For decades, bioMérieux has been an industry leader in microbiology innovation. With the introduction of Vitek Compact Pro, we are continuing this journey and delivering on the specialized needs of our customers—supporting laboratories with simplified, efficient workflows and the latest technology to optimize their experience. Through ongoing expansion of our Vitek solutions portfolio, bioMérieux continues to strengthen our comprehensive AMR/AMS offer and reinforce our commitment to provide next-generation ID/AST systems to healthcare and laboratory professionals around the world,” said Jennifer Zinn, the executive vice president of Clinical Operations at bioMérieux.
For industrial applications, the Vitek Compact Pro will be used for routine ID of pathogens to ensure the quality and safety of food, pharmaceutical and cosmetic products.
The commercial launch is initially planned in selected countries, followed by global launch starting in the second quarter of 2025.